Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
5596 studies found for:    Autoimmune
Show Display Options
Rank Status Study
21 Completed Effect of High-protein High-fiber Diet in Patients With Autoimmune Hepatitis
Conditions: Autoimmune Hepatitis;   Cirrhosis
Intervention: Dietary Supplement: High protein high fiber diet
22 Completed Confirmation of Systemic Autoimmune Diseases in the Agricultural Health Study
Condition: Autoimmune Disease
Intervention:
23 Recruiting Study of Autoimmune Lymphoproliferative Syndrome (ALPS)
Conditions: Autoimmune Disease;   Lymphatic Disease;   Lymphoproliferative Disorder;   Canale-Smith Syndrome
Intervention:
24 Completed Low-Level Laser Therapy in Chronic Autoimmune Thyroiditis
Condition: Autoimmune Thyroiditis
Intervention: Device: Low-level Laser therapy
25 Recruiting Cyclosporine-A Versus Prednisolone for Induction of Remission in Auto-immune Hepatitis
Condition: Autoimmune Hepatitis
Intervention: Drug: Cyclosporine-A
26 Completed LCP-Tacro vs. Azathioprine for the Treatment of Autoimmune Hepatitis
Condition: Autoimmune Hepatitis
Interventions: Drug: LCP-Tacro (tacrolimus);   Drug: Azathioprine
27 Recruiting Induction of Regulatory t Cells by Low Dose il2 in Autoimmune and Inflammatory Diseases
Conditions: Rheumatoid Arthritis;   Ankylosing Spondylitis;   Systemic Lupus Erythematosus;   Psoriasis;   Behcet's Disease;   Wegener's Granulomatosis;   Takayasu's Disease;   Crohn's Disease;   Ulcerative Colitis;   Autoimmune Hepatitis;   Sclerosing Cholangitis
Intervention: Drug: Interleukin 2
28 Recruiting Low Level Laser Therapy for Autoimmune Thyroiditis
Condition: Autoimmune Thyroiditis
Interventions: Procedure: Low-level laser therapy;   Procedure: Non laser ordinary red light
29 Completed Rituximab for Autoimmune Retinopathy
Condition: Autoimmune Disease
Intervention: Drug: Rituximab
30 Completed Alemtuzumab and Rituximab in the Treatment of Refractory Autoimmune Cytopenias
Conditions: Idiopathic Thrombocytopenic Purpura;   Anemia, Hemolytic, Autoimmune
Intervention: Drug: Alemtuzumab, Rituximab
31 Completed Pyrimethamine to Treat Autoimmune Lymphoproliferative Syndrome
Conditions: Autoimmune Disease;   Lymphatic Disease;   Lymphoproliferative Disorder
Intervention: Drug: Pyrimethamine
32 Withdrawn Oral Budesonide in the Treatment of Patients With Primary Biliary Cirrhosis and Overlap Features of Autoimmune Hepatitis
Conditions: Primary Biliary Cirrhosis;   Autoimmune Hepatitis
Intervention: Drug: Budesonide
33 Terminated The Efficacy and Safety of Alemtuzumab in Auotoimmune Cytopenias
Condition: Autoimmune Cytopenias
Intervention: Drug: Alemtuzumab
34 Unknown  Autologous Hematopoietic Stem Cell Transplantation for Refractory Autoimmune Diseases
Condition: Autoimmune Diseases
Intervention: Procedure: Autologous hematopoietic stem cell transplantation
35 Withdrawn Autoimmune Diabetes: Markers of the Disease and Treatment of Latent Autoimmune Diabetes in Adults (LADA)
Condition: Autoimmune Diabetes
Intervention:
36 Recruiting Clinical Characteristics of Allergy, Autoimmune and Rheumatic Diseases: A Ten Year Retrospective Study
Conditions: Allergy;   Autoimmune Diseases;   Rheumatic Diseases
Intervention:
37 Completed The RITAI Cohort: An Observational Study on Rituximab Off-label Use for Auto-immune Disorders
Conditions: Pemphigus;   Auto-immune Thrombocytopenic Purpura;   Hemolytic Auto-immune Anaemia;   Cold Agglutinin Disease;   Cryoglobulinemia
Intervention: Drug: Rituximab (MABTHERA® or RITUXAN®).
38 Completed Pyrimethamine and Sulfadoxine for Treatment of Autoimmune Lymphoproliferative Syndrome
Conditions: Autoimmune Disease;   Lymphoproliferative Disorder
Intervention: Drug: Fansidar (pyrimethamine and sulfadoxine)
39 Completed Evaluating the Dietary Supplement Anatabloc in Thyroid Health-ASAP (Antabloc Supplementation Autoimmune Prevention)
Condition: Thyroiditis, Autoimmune
Interventions: Dietary Supplement: Anatabloc Supplement;   Dietary Supplement: Placebo
40 Completed
Has Results
Gastrointestinal and Health-related Quality of Life Outcomes in Patients With Autoimmune Diseases Treated With Mycophenolate
Condition: Autoimmune Disease
Intervention: Drug: Enteric-coated Mycophenolate Sodium

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years